WO1998010273A1 - Methods and materials for optimization of electronic hybridization reactions - Google Patents
Methods and materials for optimization of electronic hybridization reactions Download PDFInfo
- Publication number
- WO1998010273A1 WO1998010273A1 PCT/US1997/014489 US9714489W WO9810273A1 WO 1998010273 A1 WO1998010273 A1 WO 1998010273A1 US 9714489 W US9714489 W US 9714489W WO 9810273 A1 WO9810273 A1 WO 9810273A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- buffer
- hybridization
- nucleic acids
- target nucleic
- factor
- Prior art date
Links
- 238000009396 hybridization Methods 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims description 37
- 238000006243 chemical reaction Methods 0.000 title abstract description 12
- 239000000463 material Substances 0.000 title description 2
- 238000005457 optimization Methods 0.000 title description 2
- 239000000872 buffer Substances 0.000 claims abstract description 67
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000018417 cysteine Nutrition 0.000 claims abstract description 26
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000012360 testing method Methods 0.000 claims abstract description 11
- 238000004377 microelectronic Methods 0.000 claims abstract description 7
- 230000005684 electric field Effects 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000009825 accumulation Methods 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 150000007523 nucleic acids Chemical class 0.000 claims 21
- 102000039446 nucleic acids Human genes 0.000 claims 21
- 108020004707 nucleic acids Proteins 0.000 claims 21
- 229930014626 natural product Natural products 0.000 claims 2
- 230000002708 enhancing effect Effects 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 abstract description 17
- 235000001014 amino acid Nutrition 0.000 abstract description 16
- 239000003792 electrolyte Substances 0.000 abstract description 15
- 239000007853 buffer solution Substances 0.000 abstract description 6
- 108020004414 DNA Proteins 0.000 description 43
- 235000014304 histidine Nutrition 0.000 description 23
- 230000003139 buffering effect Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 150000001768 cations Chemical class 0.000 description 6
- 239000001488 sodium phosphate Substances 0.000 description 6
- 229910000162 sodium phosphate Inorganic materials 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 6
- 239000012491 analyte Substances 0.000 description 5
- 239000008151 electrolyte solution Substances 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 239000006173 Good's buffer Substances 0.000 description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229940021013 electrolyte solution Drugs 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- 108091036333 Rapid DNA Proteins 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 229920001222 biopolymer Polymers 0.000 description 3
- 238000005251 capillar electrophoresis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 206010013457 Dissociation Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
- 239000007997 Tricine buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 208000034953 Twin anemia-polycythemia sequence Diseases 0.000 description 1
- 238000002479 acid--base titration Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000007998 bicine buffer Substances 0.000 description 1
- 239000008364 bulk solution Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004720 dielectrophoresis Methods 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- URSLCTBXQMKCFE-UHFFFAOYSA-N dihydrogenborate Chemical compound OB(O)[O-] URSLCTBXQMKCFE-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 208000018459 dissociative disease Diseases 0.000 description 1
- 238000010291 electrical method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012145 high-salt buffer Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 238000002218 isotachophoresis Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- -1 organic acid salts Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical group 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 238000012358 sourcing Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10D—INORGANIC ELECTRIC SEMICONDUCTOR DEVICES
- H10D64/00—Electrodes of devices having potential barriers
- H10D64/01—Manufacture or treatment
- H10D64/021—Manufacture or treatment using multiple gate spacer layers, e.g. bilayered sidewall spacers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6832—Enhancement of hybridisation reaction
Definitions
- This invention relates to buffers and electrolytes for use in electronic devices adapted for medical diagnostic, biological and other uses. More particularly, it relates to buffers and electrolytes for advantageous use with DNA hybridization analysis carried out on microelectronic medical diagnostic devices.
- APEX systems are able to perform a wide variety of functions which are advantageously used in molecular biology reactions, such as nucleic acid hybridizations, antibody/antigen reactions, clinical diagnostics, and biopolymer synthesis.
- APEX-type devices utilize buffers and electrolytes for their operation.
- a buffer has been defined as a chemical solution which is resistant to change in pH on the addition of acid or alkali. See., e.g., Dictionary of Biotechnology, Second Edition, James Coombs, Stockton Press. As stated there, "traditionally, buffers based on inorganic salts (phosphate, carbonate) and organic acid salts (acetate, citrate, succinate, glycine, maleate, barbiturates, etc.) were used in biological experiments.” It is the object of this invention to discover buffers and electrolytes which are advantageously used in molecular biology electronic devices which perform hybridizations, reactions, diagnostics or synthesis.
- the following inventions relate to our discoveries concerning the various parameters, electrolytes (buffers) , and other conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in our APEX microelectronic chips and devices.
- this invention relates to the discovery that low conductance zwitterionic buffer solutions, especially those containing the amino acid Histidine prepared at concentrations of 10-100 mM, preferably about 50 mM, and at or near the pi (isoelectric point -pH 7.47), provide optimal conditions for both rapid DNA transport and efficient hybridization reactions.
- Hybridization efficiencies of at least a factor of 10 relative to the next best known buffer, Cysteine are achieved.
- Test data demonstrate an approximately 50,000 fold increase in hybridization efficiency compared to Cysteine.
- Fig. 1 is a plan view of a checkerboard arrangement utilizing a histidine buffer.
- Genosensor impedance sensors
- Optical and Electrical Methods and Apparatus for Molecular Detection 093/22678
- dielectrophoresis devices see, e.g., Washizu 25 Journal of Electrostatics, 109-123, 1990
- AC electric fields An important distinction related to these devices is that when these AC fields are applied, there is essentially no net current flow in any of these systems, i.e, there is no electrophoretic propulsion for transport of the charged molecules.
- APEX type devices produce significant net direct current (DC) flow when a voltage is applied, which is recognized as "the signature of electrophoresis” .
- electrophore- sis the migration of ions or charged particles is produced by electrical forces along the direction of the electric field gradient, and the relationship of current and voltage are important to this technology.
- I is the electric current [A] .
- the resistance of the solution is the reciprocal of the conductance which can be measured by a conductomete .
- the conductance depends mainly on the ionic species of the buffer/electrolytes and their concentration; therefore these parameters are very important for electric field related molecular biology technology.
- the basic current/voltage relationships are essentially the same for the APEX technology as for any other electrophoretic system, although the electric fields produced are in truly microscopic environments.
- There are unique features of the APEX system regarding the various ways of sourcing the current and voltage, and how the current and voltage scenarios have been found to improve the performance of such systems . In particular, various DC pulsing procedures (linear and logarithmic gradients) appear to provide improved hybridization stringency.
- the ionic strength and conductance are equivalent, i.e., the conductance will usually be proportional to the ionic strength.
- buffering electrolytes phospr e, acetate, citrate, succinate, etc.
- the ionic strength and conductance will usually be equivalent, i.e., conductance is proportional to the ionic strength.
- an amino acid in its zwitterionic state ( " OOC-CH(R) -NH 3 *) will have a conductance value which will be approximately 1000 fold lower than when the " amino acid moiety" has a full net positive charge (HOOC-CH(R) -NH 2 * ⁇ > x" ) or a full negative charge (Y + ⁇ > " OOC-CH (R) -NH 2 ) .
- a formal negative or positive charge develops on the amino acid moiety as it moves away from its pi, and the conductivity and ionic strength will begin to correlate.
- the conductance will be much lower than is expected for that given ionic strength or concentration.
- electrophoresis texts refer to the Good Buffers and amino acid buffers as having "low conductances at high ionic strength or concentration" (see page 88 of Capillary Electrophoresis: Principles and Practice", R. Kuhn and S. Hoffstetter, Springer - Verlag, 1993) .
- a commonly used electrophoresis buffer “Tris-Borate” actually has a significantly lower conductivity than would be expected from its ionic strength or concentration. This may be due to the "tris cation” and “borate anion” forming a relatively stable zwitterionic complex in solution.
- the conductivity of a 100 mM Tris-Borate solution was determined to be 694 ⁇ S/cm, which is approximately 20 times lower than would be expected from its ionic strength, and is roughly equiva- lent to a 5 mM sodium phosphate or sodium chloride solution.
- Table 1 shows conductivity measurements of a number of transport buffers.
- Amino acid buffers do have buffer properties at their pi's. While a given amino acid may or may not have its "highest buffering capacity" at its pi, it will have some degree of buffering capacity. Buffer capacity decreases by a factor of 10 for every pH unit difference between the pi and the pKa; those amino acids with three ionizable groups (histidine, cysteine, lysine, glutamic acid, aspartic acid, etc.) generally have higher buffering capacities at their pi's than those amino acids with only two dissociations (glycine, alanine, leucine, etc.).
- Histidine has been proposed as a buffer for use in gel electrophoresis, see, e.g., U.S. Patent 4,936,963, but hybridization is not performed in such systems. Cysteine is in a more intermediate position, with regard to buffering capacity.
- the pi of cysteine is 5.02, the pKa for the carboxyl group is 1.71, the pKa for the sulfhydryl is 8.33, and the pKa for amino group is 10.78.
- An acid /base titration curve of 250 mM cysteine shows that cysteine has a better "buffering capacity" at ⁇ pH 5 than a 20 mM sodium phosphate. In the pH 4 to 6 range, the buffering capacity of cysteine is significantly better than 20 mM sodium phosphate, particularly at the higher pH.
- Fig. 1 shows a plan view of an APEX chip using histidine.
- the instant invention relates to our discoveries concerning the various parameters, electrolytes (buffers) , and other, conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in electric field molecular biology devices, especially APEX microelectronic chips and devices.
- this invention relates to our discovery that low conductance zwitterionic buffer solutions containing the amino acid Histidine prepared at concentrations of 10-100 mM, especially about 50 mM, at or near the pi (isoelectric point -7.47), provide optimal conditions for both rapid electrophoretic DNA transport and efficient hybridization reactions. This advantage of the Histidine buffer is particularly important for the APEX chip type devices .
- Table 2 shows the effect of various zwitterionic amino acid buffers [j ⁇ -Alanine, Taurine, Cysteine, Histidine, Lysine, and Sodium Phosphate (not a zwitterionic buffer) ] on the hybridizability of the transported target DNA to the specific capture DNA at the test site.
- transport the conductivity generally correlates with transport under the same field conditions.
- 3-Alanine, Taurine and Cysteine show excellent transport
- Histidine shows good transport
- Lysine and NaP0 4 show fair transport.
- the DNA hybridization sensitivity is reported for "normal DNA" which has negatively charged polyanionic phosphate backbone.
- Table 2 also reports the sensitivity for the streptavidin/biotin DNA probe capture affinity.
- Table 2 clearly shows the correlation of DNA transport (accumulation) with low conductivity (j ⁇ -Alanine, Taurine, Cysteine, Histidine) .
- the table shows good
- Histidine is the only one which provides both good transport and good DNA/DNA hybridization efficiency. It is believed that the low conductivity of the Histidine buffer system accounts for the rapid DNA transport (accumulation) . There are several possible explanations as to why the Histidine buffer produces relatively efficient DNA/DNA hybridization.
- One advantage may be the good buffering capacity of Histidine. With its pi at 7.47, Histidine will buffer well under both acidic or basic conditions (see A.L. Lehninger, Biochemistry, 2ed, Worth Publishers, New York, 1975, Fig. 4-9 on page 80) .
- the APEX chip produces acid at the positive electrode where the DNA is accumulated for hybridization, and Histidine may effectively buffer these conditions.
- DNA/DNA/Histidine may also form some type of stabilizing adduct from other electrochemical products being produced at the positive electrode (hydrogen peroxide, etc.) While the instant embodiment utilizes naturally occurring Histidine, this invention is fully applicable to other natural or synthetic compounds which have good buffering capacity, low conductivity (or zwitterionic characteristics) and have properties which allow DNA hybridization to be stabilized by charge stabilization or adduct formation.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Electrochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002264780A CA2264780C (en) | 1996-09-06 | 1997-08-18 | Methods and materials for optimization of electronic hybridization reactions |
JP51267698A JP4213216B2 (en) | 1996-09-06 | 1997-08-18 | Methods and materials for optimizing electronic hybridization reactions |
EP97938378A EP1019711A4 (en) | 1996-09-06 | 1997-08-18 | METHOD AND MATERIALS FOR OPTIMIZING THE ELECTRONIC HYBRIDIZATION REACTION |
AU40719/97A AU723564B2 (en) | 1996-09-06 | 1997-08-18 | Methods and materials for optimization of electronic hybridization reactions |
NZ334314A NZ334314A (en) | 1996-09-06 | 1997-08-18 | Methods and materials for optimization of electronic hybridization reactions |
BR9712800-7A BR9712800A (en) | 1996-09-06 | 1997-08-18 | Processes and materials for optimization of electronic hybridization reactions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70826296A | 1996-09-06 | 1996-09-06 | |
US08/708,262 | 1996-09-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998010273A1 true WO1998010273A1 (en) | 1998-03-12 |
WO1998010273A9 WO1998010273A9 (en) | 1998-07-23 |
Family
ID=24845074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/014489 WO1998010273A1 (en) | 1996-09-06 | 1997-08-18 | Methods and materials for optimization of electronic hybridization reactions |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1019711A4 (en) |
JP (1) | JP4213216B2 (en) |
KR (1) | KR100591626B1 (en) |
CN (1) | CN1180248C (en) |
AU (1) | AU723564B2 (en) |
BR (1) | BR9712800A (en) |
CA (1) | CA2264780C (en) |
NZ (1) | NZ334314A (en) |
WO (1) | WO1998010273A1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5964995A (en) * | 1997-04-04 | 1999-10-12 | Caliper Technologies Corp. | Methods and systems for enhanced fluid transport |
EP1036085A1 (en) * | 1997-12-05 | 2000-09-20 | Nanogen, Inc. | Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics |
US6238909B1 (en) * | 1999-05-04 | 2001-05-29 | Motorola, Inc. | Method and apparatus for obtaining electric field-enhanced bioconjugation |
US6468742B2 (en) | 1993-11-01 | 2002-10-22 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip |
US6492122B2 (en) | 2000-11-09 | 2002-12-10 | Nanogen, Inc. | Quantitative analysis methods on active electronic microarrays |
AU783169B2 (en) * | 1999-09-27 | 2005-09-29 | Monsanto Technology Llc | Methods for determining oils in seeds |
EP1643248A1 (en) * | 2003-06-13 | 2006-04-05 | Riken | Substrate for biomolecule microarray, biomolecule microarray, device and method for interaction acceleration, and interaction detecting method |
US7153687B2 (en) | 2002-08-13 | 2006-12-26 | Hong Kong Dna Chips Limited | Apparatus and methods for detecting DNA in biological samples |
EP1794181A2 (en) * | 2004-09-23 | 2007-06-13 | Nanogen, Inc. | Methods and materials for optimization of electronic transportation and hybridization reactions |
EP1842922A1 (en) * | 2006-04-07 | 2007-10-10 | Samsung Electronics Co., Ltd. | Method of increasing specificity of nucleic acid hybridization using zwitterionic compound |
US7309581B2 (en) * | 2000-11-01 | 2007-12-18 | Sysmex Corporation | Method of staining, detection and counting bacteria, and a diluent for bacterial stain |
RU2315299C1 (en) * | 2006-09-20 | 2008-01-20 | Государственное научное учреждение Всероссийский научно-исследовательский институт пищевой биотехнологии Российской академии сельскохозяйственных наук | Working electrolyte for determining ion composition of liquid media using capillary electrophoresis |
US7582421B2 (en) | 1993-11-01 | 2009-09-01 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip |
US9127308B2 (en) | 2002-03-07 | 2015-09-08 | Atlas Genetics Limited | Nucleic acid probes, their synthesis and use |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4936963A (en) * | 1987-05-27 | 1990-06-26 | Abbott Laboratories | Polycationic buffers and method for gel electrophoresis of nucleic acids |
US5436129A (en) * | 1989-11-17 | 1995-07-25 | Gene Tec Corp. | Process for specimen handling for analysis of nucleic acids |
US5593838A (en) * | 1994-11-10 | 1997-01-14 | David Sarnoff Research Center, Inc. | Partitioned microelectronic device array |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6017696A (en) * | 1993-11-01 | 2000-01-25 | Nanogen, Inc. | Methods for electronic stringency control for molecular biological analysis and diagnostics |
JP3398749B2 (en) * | 1994-11-10 | 2003-04-21 | オーキッド バイオ サイエンシズ, インコーポレイテッド | Liquid distribution system |
-
1997
- 1997-08-18 CN CNB97197960XA patent/CN1180248C/en not_active Expired - Fee Related
- 1997-08-18 JP JP51267698A patent/JP4213216B2/en not_active Expired - Lifetime
- 1997-08-18 KR KR1019997001868A patent/KR100591626B1/en not_active Expired - Fee Related
- 1997-08-18 AU AU40719/97A patent/AU723564B2/en not_active Ceased
- 1997-08-18 EP EP97938378A patent/EP1019711A4/en not_active Withdrawn
- 1997-08-18 BR BR9712800-7A patent/BR9712800A/en unknown
- 1997-08-18 NZ NZ334314A patent/NZ334314A/en unknown
- 1997-08-18 WO PCT/US1997/014489 patent/WO1998010273A1/en active IP Right Grant
- 1997-08-18 CA CA002264780A patent/CA2264780C/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4936963A (en) * | 1987-05-27 | 1990-06-26 | Abbott Laboratories | Polycationic buffers and method for gel electrophoresis of nucleic acids |
US5436129A (en) * | 1989-11-17 | 1995-07-25 | Gene Tec Corp. | Process for specimen handling for analysis of nucleic acids |
US5593838A (en) * | 1994-11-10 | 1997-01-14 | David Sarnoff Research Center, Inc. | Partitioned microelectronic device array |
Non-Patent Citations (1)
Title |
---|
See also references of EP1019711A4 * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6468742B2 (en) | 1993-11-01 | 2002-10-22 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip |
US7582421B2 (en) | 1993-11-01 | 2009-09-01 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip |
US6129826A (en) * | 1997-04-04 | 2000-10-10 | Caliper Technologies Corp. | Methods and systems for enhanced fluid transport |
US6471841B1 (en) | 1997-04-04 | 2002-10-29 | Caliper Technologies Corp. | Methods and systems for enhanced fluid transport |
US5964995A (en) * | 1997-04-04 | 1999-10-12 | Caliper Technologies Corp. | Methods and systems for enhanced fluid transport |
EP1036085A4 (en) * | 1997-12-05 | 2004-11-17 | Nanogen Inc | INTEGRATED SELF-ADDRESSING AND SELF-ASSEMBLING MICROELECTRONIC SYSTEMS, CONSTITUENT DEVICES, MECHANISMS, METHODS AND METHODS FOR DIAGNOSIS AND ANALYSIS OF MOLECULAR BIOLOGY |
EP1036085A1 (en) * | 1997-12-05 | 2000-09-20 | Nanogen, Inc. | Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics |
US6238909B1 (en) * | 1999-05-04 | 2001-05-29 | Motorola, Inc. | Method and apparatus for obtaining electric field-enhanced bioconjugation |
AU783169B2 (en) * | 1999-09-27 | 2005-09-29 | Monsanto Technology Llc | Methods for determining oils in seeds |
US7309581B2 (en) * | 2000-11-01 | 2007-12-18 | Sysmex Corporation | Method of staining, detection and counting bacteria, and a diluent for bacterial stain |
EP1341932A4 (en) * | 2000-11-09 | 2005-11-23 | Nanogen Inc | IMPROVED METHODS OF MONITORING GENE EXPRESSION ON ELECTRONIC MICROARRAYS |
EP1341932A2 (en) * | 2000-11-09 | 2003-09-10 | Nanogen, Inc. | Improved methods for gene expression monitoring on electronic microarrays |
US6492122B2 (en) | 2000-11-09 | 2002-12-10 | Nanogen, Inc. | Quantitative analysis methods on active electronic microarrays |
US10094800B2 (en) | 2002-03-07 | 2018-10-09 | Atlas Genetics Limited | Assays and apparatus for detecting electrochemical active markers in an electric field |
US9127308B2 (en) | 2002-03-07 | 2015-09-08 | Atlas Genetics Limited | Nucleic acid probes, their synthesis and use |
US7153687B2 (en) | 2002-08-13 | 2006-12-26 | Hong Kong Dna Chips Limited | Apparatus and methods for detecting DNA in biological samples |
US7749705B2 (en) | 2002-08-13 | 2010-07-06 | Hai Kang Life Corporation Limited | Apparatus and methods for detecting DNA in biological samples |
US8110669B2 (en) | 2002-08-13 | 2012-02-07 | Hai Kang Life Corporation Limited | Apparatus and methods for detecting DNA in biological samples |
US8198070B2 (en) | 2002-08-13 | 2012-06-12 | Hai Kang Life Corporation Limited | Apparatus and methods for detecting DNA in biological samples |
EP1643248A4 (en) * | 2003-06-13 | 2008-05-14 | Riken | SUBSTRATE FOR BIOMOLECULE MICROARRAY, BIOMOLECULE MICROARRAY, DEVICE AND METHOD FOR ACCELERATING INTERACTIONS, AND METHOD FOR DETECTING INTERACTIONS |
US7541195B2 (en) | 2003-06-13 | 2009-06-02 | Riken | Substrate for biomolecule microarray, biomolecule microarray, device and method of promoting interaction, and method of detecting interaction |
EP1643248A1 (en) * | 2003-06-13 | 2006-04-05 | Riken | Substrate for biomolecule microarray, biomolecule microarray, device and method for interaction acceleration, and interaction detecting method |
EP1794181A4 (en) * | 2004-09-23 | 2009-02-25 | Nanogen Inc | METHODS AND MATERIALS FOR OPTIMIZING ELECTRONIC TRANSPORT AND HYBRIDIZATION REACTIONS |
EP1794181A2 (en) * | 2004-09-23 | 2007-06-13 | Nanogen, Inc. | Methods and materials for optimization of electronic transportation and hybridization reactions |
EP1842922A1 (en) * | 2006-04-07 | 2007-10-10 | Samsung Electronics Co., Ltd. | Method of increasing specificity of nucleic acid hybridization using zwitterionic compound |
CN101886131B (en) * | 2006-04-07 | 2013-03-20 | 三星电子株式会社 | Method of increasing specificity of nucleic acid hybridization using zwitterionic compound |
RU2315299C1 (en) * | 2006-09-20 | 2008-01-20 | Государственное научное учреждение Всероссийский научно-исследовательский институт пищевой биотехнологии Российской академии сельскохозяйственных наук | Working electrolyte for determining ion composition of liquid media using capillary electrophoresis |
Also Published As
Publication number | Publication date |
---|---|
JP2001501301A (en) | 2001-01-30 |
AU723564B2 (en) | 2000-08-31 |
EP1019711A1 (en) | 2000-07-19 |
BR9712800A (en) | 1999-11-23 |
CA2264780C (en) | 2006-08-01 |
AU4071997A (en) | 1998-03-26 |
EP1019711A4 (en) | 2001-06-13 |
CN1180248C (en) | 2004-12-15 |
NZ334314A (en) | 2000-09-29 |
CN1230255A (en) | 1999-09-29 |
KR100591626B1 (en) | 2006-06-20 |
KR20010029477A (en) | 2001-04-06 |
JP4213216B2 (en) | 2009-01-21 |
CA2264780A1 (en) | 1998-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU723564B2 (en) | Methods and materials for optimization of electronic hybridization reactions | |
WO1998010273A9 (en) | Methods and materials for optimization of electronic hybridization reactions | |
Rabilloud | Use of thiourea to increase the solubility of membrane proteins in two‐dimensional electrophoresis | |
US4787963A (en) | Method and means for annealing complementary nucleic acid molecules at an accelerated rate | |
US20080314751A1 (en) | Electrophoretic Separation of Analytes by Molecular Mass | |
Iborra et al. | Protein subunit mapping. A sensitive high resolution method | |
Kartsova et al. | Preconcentration techniques in capillary electrophoresis | |
Wang et al. | On-line concentration of trace proteins by pH junctions in capillary electrophoresis with UV absorption detection | |
Cifuentes et al. | Separation of basic proteins by capillary electrophoresis using cross-linked polyacrylamide-coated capillaries and cationic buffer additives | |
US20130008795A1 (en) | Electrophoresis apparatus | |
US20140114053A1 (en) | Electrophoresis Separation Methods | |
Chun et al. | Protein analysis with large volume sample stacking with an electrosmotic flow pump: a potential approach for proteomics | |
Li et al. | Negatively charged sol‐gel column with stable electroosmotic flow for online preconcentration of zwitterionic biomolecules in capillary electromigration separations | |
JPH10500489A (en) | Method for desalting biological samples to remove interfering substances in isoelectric focusing | |
US7314542B2 (en) | Methods and materials for optimization of electronic transportation and hybridization reactions | |
US20050072674A1 (en) | Method and device for introducing a sample into an electrophoretic apparatus | |
WO2010017109A1 (en) | Systems and methods for quantitative analyte transfer | |
JP2003114216A (en) | Electrophoretic device | |
JPH05508931A (en) | Improvement of gel-in-gel composition for in-liquid gel electrophoresis | |
Doble et al. | Factors influencing the choice of buffer in background electrolytes for indirect detection of fast anions by capillary electrophoresis | |
WO2002070111A2 (en) | Method for the manufacture of gradient gels and method for analysing biomolecules on ultra-long ipg gels | |
Rajput et al. | Western Blot: Theoretical Aspects | |
US20070240991A1 (en) | Gelling Electrophoresis Loading Buffer | |
Cooper et al. | Electronic gel protein transfer and identification using matrix‐assisted laser desorption/ionization‐mass spectrometry | |
CN115993388A (en) | Microarray chip, system, method and use for separating analytes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 97197960.X Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CA CN JP KR NZ |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGE 1/1, DRAWINGS, REPLACED BY A NEW PAGE 1/1; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 334314 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2264780 Country of ref document: CA Ref document number: 2264780 Country of ref document: CA Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 1998 512676 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997938378 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019997001868 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1997938378 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997001868 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019997001868 Country of ref document: KR |